DELLO SBARBA, PERSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.969
EU - Europa 8.235
AS - Asia 3.843
SA - Sud America 476
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 95
OC - Oceania 66
Totale 22.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.805
PL - Polonia 2.676
RU - Federazione Russa 2.069
IT - Italia 1.294
SG - Singapore 1.059
CN - Cina 837
HK - Hong Kong 596
SE - Svezia 566
IE - Irlanda 508
VN - Vietnam 454
BR - Brasile 365
KR - Corea 275
DE - Germania 248
FR - Francia 210
FI - Finlandia 192
IN - India 174
UA - Ucraina 169
GB - Regno Unito 138
JO - Giordania 114
CA - Canada 109
AU - Australia 65
BD - Bangladesh 58
JP - Giappone 58
CH - Svizzera 46
TR - Turchia 45
AR - Argentina 44
ID - Indonesia 42
CI - Costa d'Avorio 30
MX - Messico 24
NL - Olanda 24
BE - Belgio 21
EC - Ecuador 21
ES - Italia 21
ZA - Sudafrica 21
AT - Austria 17
IQ - Iraq 17
VE - Venezuela 17
TW - Taiwan 15
PK - Pakistan 14
TH - Thailandia 12
MA - Marocco 10
CO - Colombia 9
RO - Romania 8
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
CL - Cile 6
CR - Costa Rica 6
EG - Egitto 6
MY - Malesia 6
NG - Nigeria 6
SC - Seychelles 6
IL - Israele 5
KE - Kenya 5
KW - Kuwait 5
LT - Lituania 5
PE - Perù 5
PH - Filippine 5
AL - Albania 4
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
UY - Uruguay 4
BG - Bulgaria 3
BJ - Benin 3
DZ - Algeria 3
NP - Nepal 3
PR - Porto Rico 3
PY - Paraguay 3
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
ET - Etiopia 2
EU - Europa 2
GD - Grenada 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
MD - Moldavia 2
MM - Myanmar 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BB - Barbados 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
IR - Iran 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 22.682
Salva come PNG Salva come JPEG
Città #
Warsaw 2.673
Santa Clara 2.017
Ashburn 1.148
Fairfield 795
Singapore 775
Chandler 614
Dublin 506
Hong Kong 487
Woodbridge 428
Seattle 348
Cambridge 346
Jacksonville 309
Houston 292
San Jose 283
Wilmington 275
Milan 274
Seoul 265
Beijing 248
Ann Arbor 204
Florence 174
Princeton 133
Buffalo 118
Lauterbourg 112
Rome 112
Ho Chi Minh City 111
Los Angeles 111
Boston 102
Lawrence 94
Boardman 92
Altamura 91
Council Bluffs 90
Hanoi 85
Dallas 84
Munich 81
Mumbai 79
The Dalles 79
Dong Ket 76
Shanghai 65
Melbourne 62
Paris 62
New York 60
San Diego 60
Moscow 59
Hefei 56
Tokyo 53
Helsinki 48
Medford 48
Kent 46
Bern 42
Orem 40
São Paulo 39
Falls Church 38
Pune 36
Turku 35
Jakarta 33
Abidjan 30
Naples 28
Redondo Beach 28
Toronto 28
Guangzhou 26
Turin 26
Phoenix 25
London 24
Bologna 23
Norwalk 23
Brussels 21
Figino 21
Clifton 20
Frankfurt am Main 19
Ottawa 19
Portsmouth 18
Da Nang 17
Chennai 16
Bari 15
Montreal 15
Yubileyny 15
Andover 14
Tianjin 14
Brooklyn 13
Palermo 13
Redwood City 13
Siena 13
Daan 12
Johannesburg 12
Miano 12
Haiphong 11
Izmir 11
Rio de Janeiro 11
Bangkok 10
Chicago 10
Columbus 10
Hillsboro 10
Venice 10
Vienna 10
Brasília 9
Stockholm 9
Atlanta 8
Barcelona 8
Belo Horizonte 8
Brescia 8
Totale 15.709
Salva come PNG Salva come JPEG
Nome #
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 386
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 376
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 363
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 353
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 343
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 342
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 337
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 335
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 335
A comparative kinetic analysis of proliferation in vitro of con-A-treated splenocytes and syngeneic leukaemia cells. 334
Metabolic aspects of cell cycle regulation in normal and cancer ceLLS. 333
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 328
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 323
NGF inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation and cytochrome c release. 307
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 296
Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release 295
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 289
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 274
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 261
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 256
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 256
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 252
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 248
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence. 248
Cancer stemness and progression: Mitochondria on the stage 247
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. 242
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 235
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 230
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 228
Cellule, tessuti e malattia - Principi di patologia generale 223
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 217
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 216
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 214
APOPTOSIS - MOLECULAR REGULATION OF CELL DEATH AND HEMATOLOGIC MALIGNANCIES 213
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 208
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 205
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 204
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 203
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 202
Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose. 198
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 197
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 197
Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage 193
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 193
Apoptosis: molecular regulation of cell death and hematologic malignancies. 190
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 189
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 187
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 183
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 183
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 182
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 182
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 182
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 180
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 178
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 178
BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake 176
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 174
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 171
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 169
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 167
v-raf confers CSF-1-independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation. 166
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 166
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 165
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 165
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 163
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 162
CITOKINE RECEPTOR SIGNAL TRANSDUCTION MECHANISMS IN IMMUNO-HEMATOPOIETIC CELLS 162
Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells 161
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 160
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 160
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 159
Alterations in CSF-1 receptor expression and protein tyrosine phosphorylation in autonomous mutants of a CSF-1 dependent macrophage cell line. 157
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 154
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 153
Tryptophan availability selectively limits NO-synthase induction in macrophages. 152
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 151
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 150
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 150
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 149
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 149
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 149
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 148
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 146
Bortezomib Specifically Targets a Subset of Hypoxia-Selected CML Stem Cells 146
ROLE OF ERK5 IN THE SURVIVAL OF MYELOID LEUKEMIA CELLS IN HYPOXIA 145
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 145
Environmental restrictions within tumor ecosystems select for a convergent hypoxia-resistant phenotype of cancer stem cells 144
ERK5 inhibition elicits cellular senescence in human melanoma cells 143
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 141
CXCR3 and αEβ7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes 141
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 140
Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. 139
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 136
Tissue Hypoxia and the Maintenance of Leukemia Stem Cells 134
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 132
Glucose Availability in Hypoxia Regulates the Selection of CML Progenitor Subsets with Different Resistance to Imatinib-Mesylate 132
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 131
Functional specificity of cytoplasmic and transmembrane tyrosine kinases: identification of 130- and 75-kilodalton substrates of c-fps/fes tyrosine kinase in macrophages. 128
Tumor angiogenesis: Thrombin and metalloproteinases in focus. 128
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 127
Totale 20.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.435
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.435
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022914 34 76 48 60 48 49 36 60 55 50 154 244
2022/20232.414 215 354 121 193 186 429 326 143 291 16 70 70
2023/2024864 45 82 123 45 66 124 52 181 21 22 68 35
2024/20255.628 199 596 346 888 1.766 766 35 294 229 164 182 163
2025/20265.956 664 750 343 378 710 267 715 280 393 392 160 904
2026/2027160 160 0 0 0 0 0 0 0 0 0 0 0
Totale 22.845